Schistosoma haematobium urinary tract complications in African migrants attending primary care facilities in Paris, France: A retrospective cohort study (2004-2018).

Objectives: Little is known about the burden of urogenital schistosomiasis (UGS) outside endemic areas. This study was aimed at describing urinary complications of UGS detected among African migrants in French primary care facilities.

Patients And Methods: A retrospective cohort study included patients with UGS diagnosed from 2004 to 2018 in 5 primary health centers in Paris.

[Failure to offer parasitology screening to vulnerable migrants in France: Epidemiology and consequences].

The "Consultations de Diagnostic et d'Orientation" (CDO), created in 1998 by the Paris Health Department, are medical consultations for vulnerable populations, which are held in municipal clinics, free of charge. More than two-thirds of CDO patients come from Africa. Our study was designed to assess and analyze whether these clinics offered consulting migrants screening for intestinal parasitic and Schistosoma haematobium infections.

[Targeted screening proposed in 6 migrant worker housing units in Paris in 2005: feasibility and impact study.].

Within the framework of the Mobile Radiological TB Screening Unit of the Health Department of Paris (DASES), six migrant worker housing units were selected to benefit from the presence of a health care professional on-site. This presence would ensure that following a chest X-Ray, residents would be offered the possibility of an interview with a general practitioner about Schistosoma haematobium (Sch. h.

[Discovery of Chlamydia trachomatis in the throat during diagnosis of secondary syphilis in an HIV+ patient].

Introduction: Chlamydia trachomatis (CT) pharyngitis has rarely been described in the literature. Studies in the last decade have shown a prevalence of less than 5%, with more women than men infected in the pharynx. Among homosexual men, only one study, conducted more than 5 years ago, detected the presence of CT in the throat (in one patient out of 13 tested).